Periodontal Biomaterials with BITE (Biofilm Immunity via T-cell Enhancement)
具有 BITE(通过 T 细胞增强的生物膜免疫)的牙周生物材料
基本信息
- 批准号:8274339
- 负责人:
- 金额:$ 40.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-15 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAdultAffectAftercareAlveolar Bone LossAmericanAnti-Bacterial AgentsAntibiotic ResistanceAntibiotic TherapyAntibioticsAntibodiesAntibody FormationAntigen PresentationAntigen ReceptorsAntigen-Presenting CellsAntigensB-Cell ActivationB-LymphocytesBacteriaBacterial AdhesinsBacterial EndocarditisBacterial InfectionsBindingBiocompatible MaterialsBiologicalBiomedical EngineeringCardiovascular systemCathetersCause of DeathCell CountCell surfaceCellsCenters for Disease Control and Prevention (U.S.)Cessation of lifeChimeric ProteinsChronicCodeComplexContact LensesCorneaCoupledCouplingCystic FibrosisDefectDendritic CellsDentalDental ImplantsDental cariesDevelopmentDevice RemovalDevicesDiseaseEncapsulatedEngineeringEnterococcus faecalisEpidemicEscherichia coliExhibitsExposure toFailureFc ReceptorFibronectinsGeneric DrugsGlycolipidsGoalsGram-Negative BacteriaGrowthGuided Tissue RegenerationHealedHeart ValvesHemorrhageHospitalsHumanImmune responseImmunityImmunizationImplantImplantation procedureIn VitroIndividualInfectionInfection preventionInflammationInflammatoryInjection of therapeutic agentLifeLigandsLungMammalian CellMannoseMeasuresMedicalMedical DeviceMembraneMemory B-LymphocyteMessenger RNAMicrobial BiofilmsMicrospheresModelingMonoclonal AntibodiesMovementMusNational Institute of Dental and Craniofacial ResearchNosocomial InfectionsOpsoninOrganismParticulatePatientsPeptide HydrolasesPeriodontal DiseasesPeriodontal Guided Tissue RegenerationPeriodontal PocketPeriodontitisPhagocytosisPlayPolymersPopulationPorphyromonas gingivalisProcessPropertyPseudomonas aeruginosaPublic HealthReportingResistance developmentRiskRoleSeriesSeverity of illnessSiteSocietiesStaphylococcus aureusStaphylococcus epidermidisStreptococcus Group BStreptococcus mutansSurfaceSystemT cell responseT-LymphocyteTechniquesTechnologyTimeTissue ModelTissuesTooth LossTooth TissueTransfectionUrinary tract infectionVaccinatedVaccine DesignVaccinesWorkWound Healingalveolar boneantimicrobialbasebiodegradable polymercostdesigndisorder preventionear infectionhealingimplantationin vivokiller T cellkillingsmacrophagemicrobialmicroorganismmiddle earmonocytemonomernanoparticlenoveloral bacteriaparticlepathogenprematurepreventprotein complexpublic health relevancereceptorreconstructionregenerativeresponsescaffoldscaling and root planingstressorsuccesstissue regenerationtraffickinguptakevector
项目摘要
DESCRIPTION (provided by applicant): Biofilms are thought to cause a significant amount of all human microbial infections, according to the Centers for Disease Control and Prevention [1]. Nosocomial infections are the fourth leading cause of death in the U.S. with >2 million cases annually (or ~10% of American hospital patients). About 60% of all such infections are associated with an implanted medical device causing >$4.5 billion medical costs in 1992 [2] and ~80,000 deaths annually [3]. Well-recognized infections involving biofilms include bacterial endocarditis, cystic fibrosis lung infections, deep wound healing, the current dental caries epidemic, periodontal disease, vaginosis, urinary tract infections, and chronic middle ear infections. Chronic periodontitis is an inflammatory disease of the supporting tissues of the teeth leading to resorption of alveolar bone and eventual tooth loss. The disease is a major public health problem in all societies and is estimated to affect up to 15% of the adult dentate population, with severe forms affecting 5 6%. The development and progression of chronic periodontitis has been associated with specific Gram-negative bacteria in subgingival plaque. Persistence of Porphyromonas gingivalis in subgingival plaque from periodontitis patients after treatment (scaling and root planing) has been reported to be significantly associated with progressive alveolar bone loss. Moreover, an increase in P. gingivalis cell numbers in subgingival plaque has been shown to correlate with disease severity as measured by attachment loss, periodontal pocket depth, and bleeding on probing. Guided tissue regeneration (GTR) techniques are increasingly being used for the treatment of periodontal defects, or in conjunction with dental implant procedures. Several studies have shown that optimal tissue regeneration cannot be expected for barrier membranes placed in sites infected by periodontopathic microorganisms. A prerequisite for tissue regeneration success is therefore an infection-free healing process. This proposal seeks to develop biomaterials that promote a life-long immunity protection against infections of long-term indwelling biomedical devices. Our goal, with NIDCR support, is to develop tissue regenerative biomaterials that will also provide a short- term defense and long-term immune response to specific bacterial colonization. For short-term immediate defense, model biomaterials will release fusion protein complexes - artificial opsonins - designed to enhance the coupling of pathogenic oral bacteria to monocyte-macrophage (MX); thus promoting phagocytosis. For long-term protection, the biomaterial will transfect antigen-presenting cells (specifically dendritic cells - DCs) to produce T- and B-cell memory and antibody expression, and potentially stimulate direct native killer T-cell responses. This two-tiered biological approach to preventing biomaterials infections will first be established in the model microbial system of Porphyromonas gingivalis (PG) colonization of periodontal tissue guided regeneration systems.
PUBLIC HEALTH RELEVANCE: Nosocomial infections are the fourth leading cause of death in the U.S. with ~60% of such infections being associated with an implanted medical device. Our goal is to develop tissue regenerative biomaterials that will also provide a short-term defense and life long immune response to specific bacterial infections
描述(由申请人提供):根据疾病控制和预防中心的说法,生物膜被认为是导致大量人类微生物感染的原因[1]。医院感染是美国第四大死亡原因,每年有超过 200 万例病例(约占美国医院患者的 10%)。所有此类感染中约 60% 与植入医疗设备有关,1992 年造成的医疗费用超过 45 亿美元[2],每年约有 80,000 人死亡[3]。众所周知的涉及生物膜的感染包括细菌性心内膜炎、囊性纤维化肺部感染、深层伤口愈合、当前的龋齿流行、牙周病、阴道病、尿路感染和慢性中耳感染。慢性牙周炎是牙齿支持组织的炎症性疾病,导致牙槽骨吸收并最终导致牙齿脱落。该疾病是所有社会的一个主要公共卫生问题,估计影响高达 15% 的成年人齿状人口,其中严重形式影响 5-6%。慢性牙周炎的发生和进展与龈下菌斑中的特定革兰氏阴性菌有关。据报道,牙周炎患者治疗(洗牙和根面平整)后龈下菌斑中牙龈卟啉单胞菌的持续存在与进行性牙槽骨流失显着相关。此外,龈下菌斑中牙龈卟啉单胞菌细胞数量的增加已被证明与通过附着丧失、牙周袋深度和探诊出血来衡量的疾病严重程度相关。引导组织再生(GTR)技术越来越多地用于治疗牙周缺损,或与牙种植手术结合使用。多项研究表明,对于放置在牙周病微生物感染部位的屏障膜来说,不能期望获得最佳的组织再生。因此,组织再生成功的先决条件是无感染的愈合过程。该提案旨在开发生物材料,以促进终身免疫保护,防止长期留置生物医学设备的感染。在 NIDCR 的支持下,我们的目标是开发组织再生生物材料,该材料还将针对特定细菌定植提供短期防御和长期免疫反应。为了实现短期即时防御,模型生物材料将释放融合蛋白复合物——人工调理素——旨在增强致病性口腔细菌与单核巨噬细胞(MX)的偶联;从而促进吞噬作用。为了实现长期保护,生物材料将转染抗原呈递细胞(特别是树突状细胞 - DC)以产生 T 细胞和 B 细胞记忆和抗体表达,并可能刺激直接的天然杀伤 T 细胞反应。这种预防生物材料感染的两层生物学方法将首先在牙周组织引导再生系统的牙龈卟啉单胞菌(PG)定植的模型微生物系统中建立。
公共卫生相关性:医院感染是美国第四大死亡原因,其中约 60% 的感染与植入医疗设备有关。我们的目标是开发组织再生生物材料,该材料还将针对特定细菌感染提供短期防御和终生免疫反应
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James D. Bryers其他文献
James D. Bryers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James D. Bryers', 18)}}的其他基金
Injectable Hydrogel Depots for Self-replicating mRNA Vaccine Delivery
用于自我复制 mRNA 疫苗递送的可注射水凝胶库
- 批准号:
10664048 - 财政年份:2022
- 资助金额:
$ 40.51万 - 项目类别:
Injectable Hydrogel Depots for Self-replicating mRNA Vaccine Delivery
用于自我复制 mRNA 疫苗递送的可注射水凝胶库
- 批准号:
10438409 - 财政年份:2022
- 资助金额:
$ 40.51万 - 项目类别:
Injectable Hydrogel Depots for Self-replicating mRNA Vaccine Delivery
用于自我复制 mRNA 疫苗递送的可注射水凝胶库
- 批准号:
10664048 - 财政年份:2022
- 资助金额:
$ 40.51万 - 项目类别:
Tissue Regeneration by Engineered Extracellular Vesicles
工程细胞外囊泡的组织再生
- 批准号:
10218210 - 财政年份:2019
- 资助金额:
$ 40.51万 - 项目类别:
Tissue Regeneration by Engineered Extracellular Vesicles
工程细胞外囊泡的组织再生
- 批准号:
10021673 - 财政年份:2019
- 资助金额:
$ 40.51万 - 项目类别:
Tissue Regeneration by Engineered Extracellular Vesicles
工程细胞外囊泡的组织再生
- 批准号:
10456835 - 财政年份:2019
- 资助金额:
$ 40.51万 - 项目类别:
Metal-titanates as Novel Inhibitors of Cariogenic Biofilms at Tooth-composite Int
金属钛酸盐作为牙齿复合材料国际中心致龋生物膜的新型抑制剂
- 批准号:
8509661 - 财政年份:2010
- 资助金额:
$ 40.51万 - 项目类别:
Metal-titanates as Novel Inhibitors of Cariogenic Biofilms at Tooth-composite Int
金属钛酸盐作为牙齿复合材料国际中心致龋生物膜的新型抑制剂
- 批准号:
8304138 - 财政年份:2010
- 资助金额:
$ 40.51万 - 项目类别:
Periodontal Biomaterials with BITE (Biofilm Immunity via T-cell Enhancement)
具有 BITE(通过 T 细胞增强的生物膜免疫)的牙周生物材料
- 批准号:
7934229 - 财政年份:2010
- 资助金额:
$ 40.51万 - 项目类别:
Metal-titanates as Novel Inhibitors of Cariogenic Biofilms at Tooth-composite Int
金属钛酸盐作为牙齿复合材料国际中心致龋生物膜的新型抑制剂
- 批准号:
8141302 - 财政年份:2010
- 资助金额:
$ 40.51万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
成人与儿童结核病发展的综合研究:细菌菌株和周围微生物组的影响
- 批准号:81961138012
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:国际(地区)合作与交流项目
统计学习影响成人汉语二语学习的认知神经机制
- 批准号:31900778
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of deep brain stimulation (DBS) on laryngeal function and associated behaviors in Parkinson Disease
深部脑刺激(DBS)对帕金森病喉功能和相关行为的影响
- 批准号:
10735930 - 财政年份:2023
- 资助金额:
$ 40.51万 - 项目类别:
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells
用于载药 CAR T 细胞的新型纳米载体技术的设计
- 批准号:
10734365 - 财政年份:2023
- 资助金额:
$ 40.51万 - 项目类别:
Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain
治疗骨关节炎疼痛的新型全身候选药物的临床前评估
- 批准号:
10642544 - 财政年份:2023
- 资助金额:
$ 40.51万 - 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 40.51万 - 项目类别:
Adult human brain tissue cultures to study neuroHIV
成人脑组织培养研究神经艾滋病毒
- 批准号:
10619170 - 财政年份:2023
- 资助金额:
$ 40.51万 - 项目类别: